Company Filing History:
Years Active: 2011
Title: Annika Ulrika Petersson: Innovator in Pharmaceutical Chemistry
Introduction
Annika Ulrika Petersson is a notable inventor based in Mölndal, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target obesity.
Latest Patents
Annika holds a patent for "Carbamoyl compounds as DGAT1 inhibitors." This patent describes DGAT-1 inhibitor compounds of formula (I), along with pharmaceutically-acceptable salts and pro-drugs. These compounds are essential in creating pharmaceutical compositions aimed at treating obesity.
Career Highlights
Annika is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her work focuses on innovative solutions in drug development, contributing to advancements in healthcare.
Collaborations
Throughout her career, Annika has collaborated with esteemed colleagues, including Petra Johannesson and Jan Magnus Johansson. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Annika Ulrika Petersson is a pioneering inventor whose work in pharmaceutical chemistry is making strides in the treatment of obesity. Her contributions through patents and collaborations continue to impact the field positively.